GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Epi Biotech Co Ltd (XKRX:446440) » Definitions » Asset Impairment Charge

Epi Biotech Co (XKRX:446440) Asset Impairment Charge : ₩0.00 Mil (TTM As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is Epi Biotech Co Asset Impairment Charge?

Epi Biotech Co's Asset Impairment Charge for the six months ended in . 20 was ₩0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was ₩0.00 Mil.


Epi Biotech Co Asset Impairment Charge Historical Data

The historical data trend for Epi Biotech Co's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epi Biotech Co Asset Impairment Charge Chart

Epi Biotech Co Annual Data
Trend
Asset Impairment Charge

Epi Biotech Co Semi-Annual Data
Asset Impairment Charge

Epi Biotech Co Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was ₩0.00 Mil.


Epi Biotech Co Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Epi Biotech Co's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


Epi Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
32, Songdogwahak-ro, Rooms 1903 and 1904, 15th floor, M-dong, Yeonsu-gu, Incheon, KOR, 21984
Epi Biotech Co Ltd is developing various pipelines for each hair loss treatment modality. It also conducts R&D in skin regeneration treatments to create commercially viable consumer products. The company specializes in hair loss treatment in Korea.

Epi Biotech Co Headlines

No Headlines